Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB08912_nanopub.RAqsbg_LI3e9j1jgfGvStc7duiLji8CGnbm_fiu-MrL1E#assertion>. }
Showing items 1 to 18 of
18
with 100 items per page.
- drugbank:DB08912 type drugbank_vocabulary:Drug assertion.
- drugbank:DB08912 label "Dabrafenib [drugbank:DB08912]" assertion.
- drugbank:DB08912 seeAlso DB08912 assertion.
- drugbank:DB08912 seeAlso tafinlar.html assertion.
- drugbank:DB08912 seeAlso tafinlar-drug.htm assertion.
- drugbank:DB08912 identifier "drugbank:DB08912" assertion.
- drugbank:DB08912 description "Dabrafenib mesylate is a reversible ATP-competitive kinase inhibitor and targets the MAPK pathway. FDA approved on May 29, 2013." assertion.
- drugbank:DB08912 title "Dabrafenib" assertion.
- drugbank:DB08912 bio2rdf_vocabulary:identifier "DB08912" assertion.
- drugbank:DB08912 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB08912 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB08912" assertion.
- drugbank:DB08912 bio2rdf_vocabulary:x-identifiers.org DB08912 assertion.
- drugbank:DB08912 drugbank_vocabulary:drugbank-id "DB08912" assertion.
- drugbank:DB08912 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB08912 drugbank_vocabulary:x-ahfs ahfs:10:00 assertion.
- drugbank:DB08912 drugbank_vocabulary:x-kegg kegg:D10064 assertion.
- drugbank:DB08912 drugbank_vocabulary:x-wikipedia wikipedia:Dabrafenib assertion.
- drugbank:DB08912 drugbank_vocabulary:x-ndc ndc:0173-0847-08 assertion.